Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Cel-Sci - 29 Year Stock Price History | CVM

Historical daily share price chart and data for Cel-Sci since 1991 adjusted for splits. The latest closing stock price for Cel-Sci as of May 29, 2020 is 13.33.
  • The all-time high Cel-Sci stock closing price was 11800.00 on November 07, 1991.
  • The Cel-Sci 52-week high stock price is 18.00, which is 35% above the current share price.
  • The Cel-Sci 52-week low stock price is 3.69, which is 72.3% below the current share price.
  • The average Cel-Sci stock price for the last 52 weeks is 9.68.
  
Cel-Sci Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 12.6338 9.0900 17.6000 7.5400 13.3300 45.68%
2019 6.1802 2.8900 9.6000 2.5800 9.1500 218.82%
2018 2.3678 1.8600 4.2600 0.8297 2.8700 51.87%
2017 2.2183 1.7725 3.9750 1.5900 1.8898 12.49%
2016 10.5651 10.0000 15.8750 1.6800 1.6800 -81.84%
2015 17.7444 15.4725 29.7500 9.2400 9.2500 -36.32%
2014 25.5468 16.2500 45.7500 13.5000 14.5250 -1.84%
2013 50.2212 69.3750 73.7500 14.1950 14.7975 -78.08%
2012 93.9612 75.0000 147.5000 67.5000 67.5000 -6.86%
2011 127.6821 206.6250 207.8750 68.7500 72.4750 -64.69%
2010 160.9908 230.0000 257.5000 112.5000 205.2500 -8.78%
2009 159.6703 77.5000 482.5000 37.5000 225.0000 215.79%
2008 134.3996 132.4750 175.0000 45.0000 71.2500 -44.11%
2007 172.5876 145.0000 240.0000 125.0000 127.4750 -8.95%
2006 189.1336 122.5250 432.5000 122.5000 140.0000 14.29%
2005 145.2032 157.5000 240.0000 112.5000 122.5000 -18.33%
2004 208.7817 287.5000 345.0000 117.5000 150.0000 -43.40%
2003 171.1012 52.5000 420.0000 42.5000 265.0000 404.76%
2002 95.8284 237.5000 292.5000 45.0000 52.5000 -77.89%
2001 356.6734 440.0000 712.5000 197.5000 237.5000 -36.67%
2000 885.1696 577.5000 3000.0000 265.0000 375.0000 -35.06%
1999 576.5972 407.5000 952.5000 407.5000 577.5000 32.00%
1998 972.5595 1547.5000 1595.0000 390.0000 437.5000 -73.56%
1997 1257.4605 1092.5000 2500.0000 717.5000 1655.0000 55.76%
1996 1513.7697 845.0000 3235.0000 672.5000 1062.5000 18.38%
1995 1047.6687 1250.0000 1875.0000 610.0000 897.5000 -12.44%
1994 2256.8452 4075.0000 4450.0000 850.0000 1025.0000 -71.53%
1993 3761.4625 4525.0000 4925.0000 3050.0000 3600.0000 -24.61%
1992 5109.4488 7275.0000 9150.0000 2825.0000 4775.0000 -40.13%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.455B $0.000B
CEL-SCI CORP. was formed to acquire and finance research and development of natural human interleukin-2 (``IL-2``) and lymphokine-related products and processes using the Co.'s proprietary cell culture technologies. The Co.'s proprietary product is sometimes referred to as MULTIKINEn, or buffy-coat interleukins, which is a combination, or ``cocktail`` of IL-2 and certain lymphokines and cytokines. MULTIKINE is a trade name of Co. Since its inception the focus of the Co.'s product development efforts has been on conducting clinical trials to test its proprietary technologies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.844B 14.52
Gilead Sciences (GILD) United States $94.479B 12.25
CSL (CSLLY) Australia $86.864B 0.00
Vertex Pharmaceuticals (VRTX) United States $71.918B 49.44
Regeneron Pharmaceuticals (REGN) United States $63.614B 24.52
Illumina (ILMN) United States $54.832B 56.35
Biogen (BIIB) United States $49.038B 8.39
Seattle Genetics (SGEN) United States $26.234B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.267B 10.86
Incyte (INCY) United States $21.857B 0.00
Moderna (MRNA) United States $20.618B 0.00
Genmab (GMAB) Denmark $20.217B 16.65
Genmab (GNMSF) Denmark $19.174B 56.92
BioMarin Pharmaceutical (BMRN) United States $19.096B 173.12
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.127B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.282B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.059B 38.67
Exact Sciences (EXAS) United States $12.562B 0.00
BeiGene (BGNE) Cayman Islands $12.557B 0.00
Sarepta Therapeutics (SRPT) United States $11.932B 0.00
BioNTech SE (BNTX) Germany $10.605B 0.00
QIAGEN (QGEN) Netherlands $9.894B 28.77
Bio-Techne Corp (TECH) United States $9.877B 65.25
Horizon Therapeutics Public (HZNP) Ireland $9.300B 22.89
ARGENX SE-ADR (ARGX) Netherlands $9.058B 0.00
Guardant Health (GH) United States $8.309B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.901B 0.00
Immunomedics (IMMU) United States $7.689B 0.00
Exelixis (EXEL) United States $7.461B 26.16
Ascendis Pharma (ASND) Denmark $7.044B 0.00
Repligen (RGEN) United States $6.758B 118.54
Acceleron Pharma (XLRN) United States $5.330B 0.00
Adaptive Biotechnologies (ADPT) United States $4.938B 0.00
Reata Pharmaceuticals (RETA) United States $4.894B 0.00
MyoKardia (MYOK) United States $4.675B 0.00
Mirati Therapeutics (MRTX) United States $4.495B 0.00
China Biologic Products (CBPO) China $4.335B 24.10
Emergent Biosolutions (EBS) United States $4.298B 28.17
MorphoSys AG (MOR) Germany $4.234B 32.84
Global Blood Therapeutics (GBT) United States $4.190B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.092B 0.00
Zai Lab (ZLAB) China $3.972B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.802B 83.08
Momenta Pharmaceuticals (MNTA) United States $3.733B 0.00
Vir Biotechnology (VIR) United States $3.721B 0.00
Blueprint Medicines (BPMC) United States $3.630B 0.00
Bluebird Bio (BLUE) United States $3.384B 0.00
Halozyme Therapeutics (HALO) United States $3.186B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.184B 0.00
Amicus Therapeutics (FOLD) United States $3.141B 0.00
NeoGenomics (NEO) United States $2.914B 212.77
Denali Therapeutics (DNLI) United States $2.896B 0.00
Arena Pharmaceuticals (ARNA) United States $2.806B 0.00
UniQure (QURE) Netherlands $2.793B 0.00
Alkermes (ALKS) Ireland $2.646B 52.09
Amarin (AMRN) Ireland $2.633B 0.00
Novavax (NVAX) United States $2.599B 0.00
Insmed (INSM) United States $2.521B 0.00
Fate Therapeutics (FATE) United States $2.503B 0.00
Alector (ALEC) United States $2.487B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.396B 0.00
Viela Bio (VIE) United States $2.327B 0.00
Principia Biopharma (PRNB) United States $2.126B 0.00
Inovio Pharmaceuticals (INO) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.862B 0.00
Epizyme (EPZM) United States $1.861B 0.00
Arvinas (ARVN) United States $1.756B 0.00
Zymeworks (ZYME) Canada $1.702B 0.00
Adverum Biotechnologies (ADVM) United States $1.625B 0.00
Ligand Pharmaceuticals (LGND) United States $1.618B 62.99
Sangamo Therapeutics (SGMO) United States $1.612B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.546B 0.00
Akcea Therapeutics (AKCA) United States $1.526B 0.00
Editas Medicine (EDIT) United States $1.501B 0.00
REGENXBIO (RGNX) United States $1.484B 0.00
Mesoblast (MESO) Australia $1.469B 0.00
Twist Bioscience (TWST) United States $1.468B 0.00
PHARMA MAR SA (PHMMF) Spain $1.405B 0.00
Intra-Cellular Therapies (ITCI) United States $1.397B 0.00
NGM Biopharmaceuticals (NGM) United States $1.390B 0.00
I-Mab (IMAB) China $1.389B 0.00
Zealand Pharma (ZEAL) Denmark $1.366B 0.00
Arcus Biosciences (RCUS) United States $1.299B 0.00
Coherus BioSciences (CHRS) United States $1.294B 9.03
Beam Therapeutics (BEAM) United States $1.288B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.216B 0.00
Mersana Therapeutics (MRSN) United States $1.161B 0.00
Myriad Genetics (MYGN) United States $1.074B 55.42
Sorrento Therapeutics (SRNE) United States $1.038B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.933B 0.00
Pharming Group (PHGUF) Netherlands $0.933B 0.00
NextCure (NXTC) United States $0.914B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.911B 0.00
Athenex (ATNX) United States $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Compugen (CGEN) Israel $0.847B 0.00
Heska (HSKA) United States $0.813B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.806B 0.00
Cue Biopharma (CUE) United States $0.774B 0.00
Cellectis S.A (CLLS) France $0.769B 0.00
Cara Therapeutics (CARA) United States $0.760B 0.00
Codexis (CDXS) United States $0.744B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.732B 0.00
Alcobra (ARCT) United States $0.731B 0.00
Kadmon Holdings (KDMN) United States $0.714B 0.00
Retrophin (RTRX) United States $0.692B 0.00
Kala Pharmaceuticals (KALA) United States $0.669B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.658B 0.00
Castle Biosciences (CSTL) United States $0.657B 0.00
NantKwest (NK) United States $0.651B 0.00
Morphic Holding (MORF) United States $0.645B 0.00
Vericel (VCEL) United States $0.642B 118.58
Adaptimmune Therapeutics (ADAP) United Kingdom $0.632B 0.00
Stemline Therapeutics (STML) United States $0.623B 0.00
Bellus Health (BLU) Canada $0.622B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.603B 5.16
Syndax Pharmaceuticals (SNDX) United States $0.579B 0.00
MeiraGTx Holdings (MGTX) United States $0.562B 0.00
Frequency Therapeutics (FREQ) United States $0.561B 0.00
Athersys (ATHX) United States $0.546B 0.00
Scholar Rock Holding (SRRK) United States $0.543B 0.00
Clovis Oncology (CLVS) United States $0.542B 0.00
DBV Technologies S.A (DBVT) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
AnaptysBio (ANAB) United States $0.525B 0.00
AC Immune SA (ACIU) Switzerland $0.516B 0.00
UROGEN PHARMA (URGN) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.485B 15.61
Agenus (AGEN) United States $0.482B 0.00
BioDelivery Sciences (BDSI) United States $0.479B 25.21
Aquinox Pharmaceuticals (NLTX) United States $0.464B 0.00
VBI Vaccines (VBIV) United States $0.457B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.455B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Dynavax Technologies (DVAX) United States $0.446B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.444B 0.00
Prothena (PRTA) Ireland $0.443B 0.00
Syros Pharmaceuticals (SYRS) United States $0.435B 0.00
Puma Biotechnology (PBYI) United States $0.426B 0.00
Merus (MRUS) Netherlands $0.411B 0.00
Albireo Pharma (ALBO) United States $0.405B 0.00
Seres Therapeutics (MCRB) United States $0.402B 0.00
MiMedx (MDXG) United States $0.401B 0.00
CytomX Therapeutics (CTMX) United States $0.401B 0.00
Intrexon (PGEN) United States $0.400B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.397B 0.00
ANI Pharmaceuticals (ANIP) United States $0.385B 7.62
PDL BioPharma (PDLI) United States $0.382B 328.00
Precision BioSciences (DTIL) United States $0.366B 0.00
WAVE Life Sciences (WVE) Singapore $0.358B 0.00
Menlo Therapeutics (MNLO) United States $0.342B 0.00
Kamada (KMDA) Israel $0.341B 14.20
Geron (GERN) United States $0.323B 0.00
Selecta Biosciences (SELB) United States $0.322B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.321B 0.00
Avid Bioservices (CDMO) United States $0.319B 0.00
MannKind (MNKD) United States $0.318B 0.00
OSMOTICA PHARM (OSMT) United States $0.306B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Verastem (VSTM) United States $0.286B 0.00
Starpharma Holdings (SPHRY) Australia $0.281B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.274B 0.00
Abeona Therapeutics (ABEO) United States $0.271B 0.00
Liquidia Technologies (LQDA) United States $0.269B 0.00
Cellular Biomedicine (CBMG) United States $0.268B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Gritstone Oncology (GRTS) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.244B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.242B 0.00
Fortress Biotech (FBIO) United States $0.242B 0.00
Northwest Biotherapeutics (NWBO) United States $0.239B 0.00
Affimed (AFMD) Germany $0.238B 0.00
HOOKIPA Pharma (HOOK) United States $0.237B 0.00
Pfenex (PFNX) United States $0.235B 0.00
XOMA (XOMA) United States $0.234B 0.00
Exicure (XCUR) United States $0.233B 0.00
Sutro Biopharma (STRO) United States $0.223B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Prometic Life Sciences (LMNL) Canada $0.218B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.217B 3.27
Pluristem Therapeutics (PSTI) Israel $0.207B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
IVERIC Bio (ISEE) United States $0.198B 0.00
ARAVIVE, INC (ARAV) United States $0.195B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
IBio (IBIO) United States $0.189B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.185B 0.00
Five Prime Therapeutics (FPRX) United States $0.184B 0.00
Aptinyx (APTX) United States $0.179B 0.00
Cerecor (CERC) United States $0.174B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Kindred Biosciences (KIN) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.168B 0.00
Aytu Bioscience (AYTU) United States $0.168B 0.00
Dyadic (DYAI) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Antibe Therapeutics (ATBPF) Canada $0.158B 0.00
TELA Bio (TELA) United States $0.156B 0.00
Theratechnologies (THTX) Canada $0.155B 0.00
Celyad SA (CYAD) Belgium $0.153B 0.00
Orgenesis (ORGS) United States $0.151B 0.00
Arbutus Biopharma (ABUS) Canada $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Cidara Therapeutics (CDTX) United States $0.146B 0.00
Trevena (TRVN) United States $0.141B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.139B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
VolitionRX (VNRX) United States $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
CorMedix Inc (CRMD) United States $0.120B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.120B 3.07
AIT Therapeutics (XAIR) United States $0.116B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Cyclerion Therapeutics (CYCN) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.106B 0.00
Windtree Therapeutics (WINT) United States $0.100B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.092B 0.00
Catalyst Biosciences (CBIO) United States $0.089B 0.00
SESEN BIO, INC (SESN) United States $0.088B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
Organovo Holdings (ONVO) United States $0.087B 0.00
Celsion (CLSN) United States $0.086B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Synlogic (SYBX) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
Emmaus Life Sciences (EMMA) United States $0.067B 0.00
Happiness Biotech Group (HAPP) China $0.066B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Signal Genetics (MGEN) United States $0.061B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Apricus Biosciences (SEEL) United States $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
CollPlant Holdings (CLGN) Israel $0.056B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Celldex Therapeutics (CLDX) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Cesca Therapeutics (THMO) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
OvaScience (MLND) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.031B 0.00
Curis (CRIS) United States $0.031B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.026B 0.00
Spherix (AIKI) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
VIVUS (VVUS) United States $0.021B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Unum Therapeutics (UMRX) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00